DENDREON PHARMACEUTICALS, LLC

Lobbying for DENDREON PHARMACEUTICALS, LLC

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · $59,650.00 expenses · posted Sep 9, 2026

Lobbying activity 1

Veterans

Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.